veligrotug

FDA Drug Profile — Lumvoa

veligrotug is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Lumvoa. Available dosage form: injection.

Drug Details

Generic Name
veligrotug
Brand Names
Lumvoa
Application Number
BLA761530
Sponsor
Viridian Therapeutics, Inc.
NDC Codes
1
Dosage Forms
INJECTION
Routes
INTRAVENOUS
Active Ingredients
VELIGROTUG

Indications and Usage

1 INDICATIONS AND USAGE LUMVOA is indicated for the treatment of thyroid eye disease regardless of thyroid eye disease activity or duration. LUMVOA is an insulin-like growth factor-1 receptor inhibitor indicated for the treatment of thyroid eye disease regardless of thyroid eye disease activity or duration. ( 1 )